Vericel Corporation reported a 22% increase in total net product revenues to $26.7 million for the first quarter of 2020, compared to $21.8 million in the first quarter of 2019. However, the company's net loss increased to $4.7 million, or $0.10 per share, compared to a net loss of $2.8 million, or $0.07 per share, for the first quarter of 2019.
Total net product revenues increased by 22% to $26.7 million.
MACI net revenue was $20.3 million, while Epicel net revenue was $6.4 million.
Net loss was $4.7 million, or $0.10 per share.
The company had $83.3 million in cash and investments as of March 31, 2020.
Due to the continued uncertainties resulting from the impact of the COVID-19 pandemic, the company has withdrawn its previously announced 2020 financial guidance.
Visualization of income flow from segment revenue to net income